Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SES and DTA for Anastomotic Healing in Rectal Cancer
NCT02682485Phase 2Withdrawn
- Sponsor
- University of Chicago
- Start
- Mar 2017
- Primary completion
- Mar 2017
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of ciprofloxacin + ibuprofen gel, metronidazole and neomycin in Anastomotic Leak (AL), sponsored by University of Chicago. Primary endpoint: Anastomotic Healing Score. Planned start Mar 2017; status: withdrawn.
02
Drugs
ciprofloxacin + ibuprofen gelmetronidazoleneomycin
03
Conditions
Anastomotic Leak (AL)
Beyond the preview
Go deeper on NCT02682485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02682485.